A new method of determining the oligosaccharide composition of commercial glycosaminoglycan heparin is described in which heparin was first depolymerized using heparin lyase (EC 4.2.2.7), and then analysed by a single h.p.l.c. step. All 20 of the porcine and bovine heparins examined were found to contain a small number of major oligosaccharide components, which on average comprised 86 o of their mass. The five most abundant oligosaccharides have defined chemical structures. Although the relative abundance of oligosaccharides varied, the heparins examined were surprisingly similar. Porcine, bovine, low-Mr, and high and low antithrombin III (ATIII)-affinity heparins, however, each had distinctly different proportions of these major oligosaccharide components. The concentration of one of these five oligosaccharides, containing a portion of the ATIII binding site, correlated with the anticoagulant activity of the ATIII-affinityfractionated porcine-mucosal heparins from which it was derived. An additional oligosaccharide of undetermined structure was found in significant quantities in both bovine heparin and high ATIII-affinity porcine-mucosal heparin. The correlation between oligosaccharide concentration and anticoagulant activity suggests that the oligosaccharide is derived from a structural variant of the ATIII-binding site. Finally, for the heparins examined chondroitin/dermatan sulphate formed 0.6-7.4% of their mass.
INTRODUCTION
Heparin is a polydisperse, highly sulphated, alternating copolymer of 1 -*4-linked glucosamine and hexuronic acid (Casu, 1985) . Although it has been closely studied for a half-century, its chemical structure still has not been established. Heparin is biosynthesized as a proteoglycan consisting of a core protein to which polysaccharide or glycosaminoglycan chains are attached (Jacobsson et al., 1984) . Although synthesized as a proteoglycan, most scientific studies on heparin's structure and biological activities are performed on commercially-prepared glycosaminoglycan heparin.
Heparin's biological activities have been classified into its effects on cells and on proteins (Jacques, 1979) . Of all these activities the most clinically important is heparin's primary use as an anticoagulant and antithrombotic agent. This activity is primarily mediated through the presence of an unique antithrombin (ATIII) binding site in the heparin polymer (Lindahl et al., 1983; Atha et al., 1984) . The presence and the number of these binding sites within a particular commercial heparin preparation can be estimated using ATIII-affinity chromatography (Hovingh et al., 1986 ), a variety of chromatogenic assays based on the ATIII-mediated inhibition of coagulation factor IIa or Xa (FlIa, FXa), or coagulation-based assays.
The structure of heparin has recently been under intensive investigation by our group Merchant et al., 1985; Linhardt et al., 1986; Rice et al., 1987) and others (Bienkowski & Conrad, 1985; Reynertson et al., 1983; Linker & Hovingh, 1984) . Generally, heparin is first depolymerized either chemically or enzymically into a mixture of oligosaccharides which is then fractionated and structurally characterized. The picture which has emerged is a heparin that is complex, comnprised of a large number of oligosaccharide components with subtle differences in sulphation, acetylation and stereochemistry. In many of these previous studies the recovery (as a wt. % of heparin) of these oligosaccharides was not accurately established, making it difficult to determine whether a given oligosaccharide represents a major or minor component of heparin's structure. This paper reports a method for the quantitative determination of heparin's composition, including the molar concentration of its ATIII-binding site. All heparin samples were prepared by dissolving approx. 20 mg into 1 ml of water and dialysing (in 3500-Mr cut-off bags at 4°C) first against 10 vol. of 1 M-NaCl followed by 3 x 1000 vol. of deionized water. After dialysis the heparins were removed from their dialysis bags and syringe filtered into pre-weighed vials, freezedried, and stored together dessicated over anhydrous CaCl2 for 2 days. Each of the heparin samples was then carefully weighed and, using a density of 2 g/ml for heparin, the appropriate value of distilled water was added to obtain a 20 mg/ml stock of solution. For example, if a heparin sample weighed exactly 20 mg, 990,l of water was added to obtain a 20 mg/ml solution. These stock solutions were stored at -70°C and dilutions were made for uronic acid assay, aPTT, antithrombin-mediated anti-FXa and anti-FIla assays, DS assay, and heparinase-catalysed depolymerization. Affinity fractionation of heparin Heparin was fractionated based on its affinity to ATIII (Denton et al., 1981) . A concanavalin A-Sepharose column (1 cm x 10 cm) at 4°C was equilibrated with 0.02 M-Tris/HCl containing 50 mM-NaCl, 1 mM-MgCl2, 1 mM-manganese chloride and 1 mM-CaCl2 at pH 7.4.
Excess ATIII (Griffith et al., 1985) , in the same buffer, was applied and 20 mg was bound to the column. Heparin [5 mg of unfractionated porcine heparin (UH) from Hepar] in 1 ml of the same buffer was loaded onto the column and the column was washed with 15 ml of starting buffer. The heparin which failed to bind (2.6 mg) was recovered in this fraction. The NaCl concentration in the buffer was increased to 0.25 M and 15 ml was used to release the heparin (1.4 mg) that was non-specifically bound to the column. Heparin bound (I mg) to the immobilized ATIII [high ATIII-affinity heparin) (HAH)] was eluted using 15 ml of the same buffer containing I MNaCl. Each fraction was dialysed, freeze-dried, redissolved in a small volume of water and its heparin concentration measured by uronic acid assay. The 2.6 mg of non-binding heparin was fractionated a second time on the same column and again the non-binding fraction was recovered, dialysed, freeze-dried, redissolved and assayed, resulting in 1.3 mg of low ATIII-affinity heparin (LAH).
Coagulation and amidolytic assays
The HAH, UH and LAH heparin samples were assayed by aPTT by first constructing a standard curve using porcine mucosal heparin (R) from 0 to 0.5 units/ml of human plasma vs. log aPTT (in s). The aPTT was determined using a manual method previously described in detail (Linhardt et al., 1982) . Each heparin was prepared in fresh citrated human plasma at several concentrations ranging from 1 to 4 jtg/ml.
The heparin samples were assayed for anti-FXa activity using a Kabi Vitrum Coatest Heparin Kit by the 'EndPoint' method. A 7-tandard curve was constructed using USP heparin from 0.1 to 0.7 units/ml of test plasma vs. absorbance at 405 nm. Test plasma containing each heparin was prepared at concentrations of 0.5-10,ug/ml.
The heparin samples were prepared (0.05-1.5 ,tg/ 340,l) in buffer containing 0.05 M-Tris/HCl, 7.5 mM-disodium ethylenediamine tetra-acetic acid and 0.15 MNaCl, pH 8.4. A standard curve was constructed using USP heparin between 0 and 0.02 units/340,1 of buffer. 
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acetic acid was added to terminate the reaction. The log absorbance at 405 mm vs. units/ml was plotted. Uronic acid determination of heparin The uronic acid content of each of the heparin samples was compared by the carbazole method (Bitter & Muir, 1962 Vol. 254 authentic sample or retention time. The identity of the peaks assigned to F1-F5, F2' and F5' in the depolymerized heparins was confirmed by comparing each with purified oligosaccharide standards analysed on a single-gradient polyacrylamide gel . Molar absorptivities, standard curves and error analysis. The five major oligosaccharides obtained from depolymerization of heparin by heparinase were prepared at > 95 % purity (Rice, 1987) and characterized Linhardt et al., 1986; Rice et al., 1987) . These compounds were desalted twice by Sephadex G-10 column chromatography, frozen, freeze-dried, and stored desiccated over anhydrous CaCl2 for several days. Three 1 mg samples of each of the purified, dried oligosaccharides were accurately weighed, dissolved in 1 ml of 0.03 M-HCI, and three dilutions of each (in 0.03 M-HCI) were prepared. Absorbance at 232 nm was determined after blanking against 0.03 M-HCI. The molar absorption coefficient (e) was calculated from the plot of absorbance at 232 nm vs. molarity determined from the Mr of the sodium salt of each compound.
Aliquots of the samples having approx. absorbance at 232 nm of 0.9 (0.173 nM), were used to construct calibration curves. These compounds were injected, using a 100 , 
RESULTS
The analysis of the heparin samples at concentrations of 5, 10 and 15 ,ug/ml by carbazole assay gave a collection of lines with an average equation: Each heparin was depolymerized under identical conditions using heparinase to afford a mixture of oligosaccharides. The rate of depolymerization, under conditions of substrate saturation, was nearly identical for all the heparins examined. An initial rate of 91.9 ,umol/min was determined with an S.D. of 8.3 ,umol/min (n = 20). The final yield of depolymerization product is shown in Table 1 . Fractionation of the depolymerization mixture by direct injection onto s.a.x.h.p.l.c. at two concentrations resulted in all peaks being on-scale and allowed the accurate determination of integration area. Five major oligosaccharide fragments (FI-F5), tentatively assigned by elution position, were observed in all heparins and their concentration is given in Table 1. Gradient-polyacrylamide-gel electrophoresis analysis was performed to check the tentative assignments made in each chromatogram Table 1 were measured to within 5 % based on these standard deviations.
A chromatogram of oligosaccharide products of the porcine mucosal heparin (P) at 4 ,ug/40 ,ul injection concentration is shown in Fig. 1 . Chromatograms (40 ,g/40 ,Al injections) of the oligosaccharide products of two different lots of porcine heparin from the same manufacturer (P and R), porcine heparin (Panheprin) from a second manufacturer (D), unbleached porcine heparin (A), low-Mr heparin chemically prepared from porcine mucosal heparin (S), and bovine lung heparin (I) are shown in Fig. 2 . ATIII-affinity fractionated heparins, LAH and HAH are shown in Fig. 3 .
Porcine heparin was fractionated on an ATIII-affinity (Fig. 2) . The concentration of contaminating DS was also determined for each heparin using chondroitinase ABC (Perlin & Folkman, 1987 
DISCUSSION
Heparin, from a variety of sources, was carefully prepared by predialysis, freeze-drying to a uniform dryness, and dissolving to a concentration of 20 mg/ml. Analysis of these stock solutions by carbazole assay confirmed that each contained a comparable mass of heparin. On treatment with heparinase all heparins gave nearly identical initial rates and similar final molar concentrations of oligosaccharide products (Table 1) .
Analysis of proteins for the presence of conserved sequences has relied heavily on peptide mapping. In an effort to develop a similar approach for heparin, the oligosaccharide maps for 15 commercial porcine mucosal heparins were prepared. At 4 ,ug/40 ,u injections all the heparins looked remarkably similar, with each showing five major oligosaccharides (Fig. 1) . These major oligosaccharides (F1-F5) are each released from the polymeric substrate at similar rates by heparinase (Rice, 1987) . In addition, each heparin shows an early peak at 8 min corresponding to a disulphated disaccharide (F2') which directly arises from the polymeric substrate, but can also be produced as the result of prolonged action of heparinase at a secondary site contained in tetrasaccharide F2 (Rice, 1987) . Oligosaccharide F4 also contains a secondary site for heparinase. Although this site is over 100-fold less sensitive to heparinase than is the polymeric substrate, prolonged enzymatic treatment results in its breakdown to 2 mol of Fl (Rice, 1987 
PDF Editor
the intensity of the minor oligosaccharide components (Fig. 2) . Two lots of porcine heparin from the same manufacturer resulted in remarkably similar maps (Fig.  2a-d) . The lot-to-lot similarity, however, was no more remarkable than the similarity between heparins from different manufacturers or between commercial and unbleached porcine heparins (Fig. 2a-d) . As little as 1 ,ug of heparin (at 0.005 AUFS) could be used to prepare an oligosaccharide map.
The picture of porcine heparin which emerges from these chromatograms is of a simple polymer which is primarily poly-Fl (Fig. 1) , but which also contains a small number of additional characterized and uncharacterized (Fig. 2a-d and F2' which is found at an average concentration of 1.6 wt. % (as judged from the Fl calibration curve and an Mr of 563) in heparin brings the average mass balance to 91 wt. %. The recovery of uncharacterized minor oligosaccharides from all commercial porcine heparins, as well as unbleached porcine heparin, suggests that these are more than just artifacts arising from the commercial processing of heparin. Although it is possible that some of these products might result from minor contaminants (sulphoesterase, sulphamidase, heparitinase) in our enzyme preparation (Yang et al., 1985) , nearly identical fragmentation patterns were observed when a commercially prepared heparinase was used. It would be unexpected for both enzyme preparations to contain identical amounts of the same minor contaminating activities. The addition of up to 10 wt. % of heparan monosulphate to a standard heparin, before depolymerization, did not appreciably alter the oligosaccharide map. Further studies using a homogeneous enzyme preparation (Yang et al., 1985) (currently available only in very small amounts) are required to resolve the question of the source of the minor oligosaccharides representing the remaining 9 % required to close mass balance. We previously published the structures of two N-acetylated tetrasaccharides derived from heparinase treatment of heparin . Although we suggested that these oligosaccharides represented major structural components of the heparin polymer, we now believe that the gel-permeation chromatography step which preceded s.a.x.h.p.l.c. enriched these two minor tetrasaccharides (corresponding to the two unassigned minor peaks at 42-54 ml in Fig. 2a-d) .
The mass balance of over 100 wt. % for bovine heparins (I and N) can be rationalized by their high Fl content. The 8 % error associated with the measurement of molar absorption coefficient for F1 (this error was particularly difficult to reduce due to residual salt in the Fl sample), when combined with a 5 % error in analysis, probably results in the high-mass recovery.
Low-Mr heparins and bovine lung heparins show similar but distinctly different oligosaccharide maps from each other and porcine heparin ( Fig. 2e and J) . Low-molecular-mass heparin contains higher concentrations of minor tetrasaccharide components eluting between 42 and 54 ml. Bovine heparin shows another major oligosaccharide eluting near F5, labelled F5' in Fig. 2. LAH and HAH were depolymerized, and their content of oligosaccharides Fl-F5 was determined (Table 1 and Fig. 3a and b) . As expected HAH resulted in a large amount of F5 on heparinase depolymerization and exhibited a high level of ATIII-mediated activities. On the other hand, the oligosaccharide mixture formed by the depolymerization of LAH was depleted in F5 and this heparin exhibited low ATIII-mediated activities. A plot of activity vs. ,ag of F5 for affinity-fractionated heparins clearly demonstrated the relationship of F5 to ATIII-mediated activity.
Like porcine heparin, bovine heparin contains the five major oligosaccharides. Unlike porcine mucosal heparin, bovine lung heparin has a considerably higher degree of N-sulphation (Linker & Hovingh, 1979) affecting the concentration of Fl, F4 and F5. Oligosaccharide F5 is greatly diminished in bovine heparin due to the fact that its major ATIII-binding site is a structural variant (Pejler et al., 1987) . A second peak appeared near F5 in the chromatogram (Fig. 2f) , labelled F5', may correspond to the structural variant of the ATIII-binding site which predominates in bovine heparin. The additional observation that this oligosaccharide is greatly enriched by ATIII-affinity chromatography (Fig. 3b) supports this premise. Further research is required to establish this point and define the precise chemical structure of F5'.
